FOR IMMEDIATE RELEASE
|
Contact:
Stephanie Lamenta
|
October 11, 2001
|
The Nixon Group
|
|
305-573-9955 ext. 221
|
|
lamenta@nixongroup.com
|
Shortcomings of Pediatric Clinical Trials One of Hot Topics at AAPS Annual
Meeting
8,000 Pharmaceutical Scientists Gather in Denver, October 21-25
ARLINGTON, Va. - October 11, 2001 -
News headlines about the pharmaceutical industry typically focus on mergers,
stock picks and the next wonder drug. But from
October 21-25 in Denver,
reporters can see another aspect of the pharmaceutical industry: the
scientists behind drug discovery and development. Scientists from academia,
industry, government and other research institutions worldwide will gather at
the
Colorado Convention Center
for the 2001 Annual Meeting of the American Association of Pharmaceutical
Scientists (AAPS): "Pharmaceutical Sciences: Climbing New Heights." Dr. Donald
Francis, whose efforts to call attention to AIDS were chronicled in the movie "
And The Band Played On,
" will formally kickoff the meeting October 21 at the opening session.
The meeting features roundtable discussions and the presentation of thousands
of new scientific research studies. Here is a sampling:
Public's Involvement in Design of Pediatric Trials Sought -
With new regulations currently under review regarding pediatric drug
clinical trials, the FDA is inviting the public to help ensure that ethical
boundaries are observed in the design and implementation of pediatric trials.
During a press conference/teleconference on Wednesday, October 24 at 10:30 a.m.
EST (9:30 a.m. CST, 8:30 a.m. MST, 7:30 a.m. PST), Steve Hirschfield, M.D.,
Ph.D., of the FDA will address the current shortcomings of the process and how
the public can join Institutional Review Boards. In addition, AAPS will provide
tips for parents wanting to enroll their children in a clinical trial.
Pharmaceutical scientists and FDA officials will focus on the challenges of
pediatric trials in two sessions.
New Weapon Against HIV and STD's -
In the U.S., more than one in three adults have an incurable STD. The
unavailability of vaccines to combat HIV and STDs has created an urgent need to
stop the spread of the infection. Using the same compound currently employed
for coating pills, scientists have developed a new product form to be used in
cream and sponge form that inactivates HIV and STDs in animals, thereby
stopping the transmission of the viruses.
Link Between Liver Damage and Prescription Drugs -
Drug-induced liver toxicity, caused by certain drugs or the combination of
drugs with other substances such as OTCs, herbal remedies, dietary supplements
and alcohol, is the leading cause of acute liver failure. This is a huge
concern for consumers and a tremendous financial drain on pharmaceutical
companies who are often forced to withdraw drugs from the market after spending
millions in R & D. John Senior, M.D., from the FDA Office of Drug Safety
will
address the reasons behind the growing problem, offer solutions for identifying
potentially toxic drugs, and recommend mechanisms to spot problem trends once a
drug is available to the consumer.
Detecting Counterfeit Medicines -
According to the World Health Organization, more than eight percent of
pharmaceuticals imported into the U.S. are counterfeit. Phony drugs can cause
dangerous interactions with other drugs, or harm consumers by not delivering
the medicines their body needs. Laws passed allowing the importation of
prescription medicines from other countries have opened the floodgates to
counterfeits and created a rapidly growing problem in the U.S. A new study
being presented at the AAPS meeting, made possible by a corroboration of
scientists from the London Medicines Control Agency and University of London,
will disclose new near-infrared methods that detect counterfeits without
damaging the integrity of the medication.
New Vaccination Hope for Fish Farms -
With the demand for fish outpacing nature's capacity to put it on the table,
fish farms have become a necessity. Currently, almost one quarter of seafood
consumed globally is "raised" rather than caught. The U.S. alone sustains a $50
billion seafood industry. Unfortunately, raising large populations of fish in
tight quarters can allow for the fast spread of viral infections, forcing the
destruction of thousands of valuable fish within days of outbreaks and creating
huge financial loses for farmers. Current vaccination methods are antiquated
and labor intensive. A new oral vaccine and antibiotic treatment that uses
coated fish pellets is an excellent alternative to the current method whereby
each fish is injected, by hand, with a vaccine or immersed in treated solutions.
About AAPS PharmSci
SM
All abstracts presented at the AAPS Annual Meeting are published in a
supplement to
AAPS PharmSci
(www.pharmsci.org)
, the organization's peer-reviewed, online journal.
AAPS PharmSci
offers a forum for the rapid exchange and dissemination of scientific
knowledge in the pharmaceutical sciences.
About AAPS
AAPS is a professional, scientific society of more than 11,000 members employed
in academia, industry, government and other research institutes worldwide.
Founded in 1986, AAPS aims to advance science through the open exchange of
scientific knowledge, serve as an information resource, and contribute to human
health through pharmaceutical research and development. For more information
about AAPS, visit AAPS Pharmaceutica at
www.aapspharmaceutica.com.
###
Editor's Note:
All abstracts presented at the Annual Meeting can be previewed online in a
fully searchable database at www.aapspharmaceutica.com/abstracts. For complete
up-to-date meeting information, visit the AAPS Annual Meeting News Room at
www.aapspharmaceutica.com/annualmeeting/pressroom.
To register for the meeting, contact Debbie Werfel at AAPS, 703-248-4743 or
WerfelD@aaps.org.
For the period of Oct. 21-25, contact Stephanie Lamenta or Debbie Werfel at
the press room in Denver at 303-228-8450.
* * *
|